A phase 1/2a dose-escalation study of oligodendrocyte progenitor cells in individuals with subacute cervical spinal cord injury.

Saved in:
Bibliographic Details
Title: A phase 1/2a dose-escalation study of oligodendrocyte progenitor cells in individuals with subacute cervical spinal cord injury.
Authors: Fessler RG; 1Department of Neurosurgery, Rush University Medical Center, Chicago, Illinois., Ehsanian R; 2Division of Physical Medicine and Rehabilitation, Department of Orthopedics & Rehabilitation, University of New Mexico School of Medicine, Albuquerque, New Mexico., Liu CY; 3USC Neurorestoration Center, Los Angeles.; 4Department of Neurological Surgery, USC Keck School of Medicine, Los Angeles.; 5Rancho Los Amigos National Rehabilitation Center, Downey., Steinberg GK; 6Department of Neurosurgery, Stanford University School of Medicine, Stanford, California., Jones L; 7Thomas Jefferson University, Philadelphia, Pennsylvania., Lebkowski JS; 8Asterias Biotherapeutics, a wholly owned subsidiary of Lineage Cell Therapeutics, Carlsbad.; 9Regenerative Patch Technologies, LLC, Menlo Park., Wirth ED; 8Asterias Biotherapeutics, a wholly owned subsidiary of Lineage Cell Therapeutics, Carlsbad.; 10Aspen Neuroscience, San Diego; and., McKenna SL; 6Department of Neurosurgery, Stanford University School of Medicine, Stanford, California.; 11Department of Physical Medicine and Rehabilitation, Santa Clara Valley Medical Center, San Jose, California.
Source: Journal of neurosurgery. Spine [J Neurosurg Spine] 2022 Jul 08; Vol. 37 (6), pp. 812-820. Date of Electronic Publication: 2022 Jul 08 (Print Publication: 2022).
Publication Type: Clinical Trial, Phase I; Multicenter Study; Journal Article
Journal Info: Publisher: American Association of Neurological Surgeons Country of Publication: United States NLM ID: 101223545 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1547-5646 (Electronic) Linking ISSN: 15475646 NLM ISO Abbreviation: J Neurosurg Spine Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1547-5646
DOI:10.3171/2022.5.SPINE22167